SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma

Background: Adrenocortical carcinoma (ACC) is an aggressive malignancy with limited medical treatment options. We previously identified polo-like kinase 1 (PLK1) as one of most overexpressed genes in ACC; thus PLK1 represents a potential treatment target for this cancer type. Some PLK1 inhibitors ar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Smith, Gabrielle, Liang, Raimunde, Chortis, Vasileios, Khan, Sana, Lippert, Juliane, Hantel, Constanze, Altieri, Barbara, Fassnacht, Martin, Foster, Paul Alexander, Ronchi, Cristina Lucia
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Tumor Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208647/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2164
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars